calcipotriene 0.005 % Topical Foam

RxCUI
1020035
RxNorm name
calcipotriene 0.005 % Topical Foam
Display name
calcipotriene 0.005 % Topical Foam
Full name
calcipotriene 0.005 % Topical Foam
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
calcipotrieneCALCIPOTRIENEMayne Pharma26756ac7-a80c-49db-97bb-351f76ad8a712024-05-09Warnings, Adverse reactionsExact identifier
rxcui: 1020035
SORILUXCALCIPOTRIENEMayne Pharma51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe2024-05-09Warnings, Adverse reactionsExact identifier
rxcui: 1020035

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51f208d0-7b3f-44cc-8bed-92fa3d2e7bbecalcipotriene 0.005 % Topical Foam [PSN] · calcipotriene 0.05 MG/ML Topical Foam [SCD] · calcipotriene 0.005 % Topical Foam [SY]37These highlights do not include all the information needed to use SORILUX safely and effectively. See full prescribing information for SORILUX. SORILUX (calcipotriene) foam, for topical use Initial U.S. Approval: 199320240509
26756ac7-a80c-49db-97bb-351f76ad8a71calcipotriene 0.005 % Topical Foam [PSN] · calcipotriene 0.05 MG/ML Topical Foam [SCD] · calcipotriene 0.005 % Topical Foam [SY]34These highlights do not include all the information needed to use calcipotriene foam safely and effectively. See full prescribing information for calcipotriene foam. CALCIPOTRIENE foam, for topical use Initial U.S. Approval: 199320240509